The Department of Veterans Affairs has agreed to readjudicate denied claims from Vietnam War veterans who served in offshore waters near Vietnam but were previously rejected because their service wasn’t on the Vietnamese mainland. Starting in April 2021, the VA began reviewing these claims under a new program that recognizes offshore service as qualifying for Agent Orange-related compensation. If you’re a veteran who served on Navy ships in offshore waters of the Republic of Vietnam between 1962 and 1975, or a survivor of such a veteran, your previously denied disability claim may now qualify for approval and back pay.
This readjudication stems from both a federal court order and major legislative changes. The Blue Water Navy Vietnam Veterans Act, passed in 2019, officially extended the presumption of herbicide exposure to veterans who served in offshore waters, making them eligible for VA compensation for conditions linked to Agent Orange. This represents a significant reversal of decades-long denials that excluded “blue water” sailors from compensation programs available to their counterparts who served on land in Vietnam. The article covers how this program works, who qualifies, the amount of compensation involved, and how the VA’s recent regulatory updates are expanding eligibility even further to include exposure at locations outside Vietnam where herbicides were stored or tested.
Table of Contents
- How Did the VA Initially Deny Offshore Vietnam Service Claims?
- What Changed with the Blue Water Navy Vietnam Veterans Act and Nehmer Consent Decree?
- The Readjudication Program and Nehmer Eligibility
- Understanding Back Pay and Compensation Amounts
- What About Veterans Who Already Died Without Receiving Benefits?
- Recent Regulatory Expansions and Additional Locations
- The Broader Legacy and Future of VA Herbicide Exposure Claims
How Did the VA Initially Deny Offshore Vietnam Service Claims?
For decades, the VA maintained a restrictive policy that only recognized herbicide exposure for veterans who served on the landmass of the Republic of Vietnam or its inland waterways. This meant that sailors aboard U.S. Navy vessels operating in offshore waters—sometimes just a few miles from the Vietnamese coast—were systematically denied claims for conditions like cancer, respiratory disease, and other ailments linked to Agent Orange exposure. The original reasoning was bureaucratic: if you weren’t physically on Vietnamese soil, the VA argued, you couldn’t have been exposed to the herbicides being sprayed there.
This denial policy persisted for over 30 years, even as scientific evidence accumulated that Agent Orange exposure could occur through contaminated water, equipment, and supplies that Navy vessels received from contaminated areas. A Navy sailor whose ship’s water supply was contaminated with dioxin-laden residue from Agent Orange would develop the same diseases as a soldier on land, yet the VA refused to recognize the connection. The result was thousands of veterans denied compensation they had earned through their military service. The roots of this restrictive approach trace back to regulations written in the 1980s, before the full extent of offshore contamination was understood or officially documented. By the time scientific evidence confirmed that offshore exposure was real and measurable, the VA’s denial machine had already rejected tens of thousands of claims—many from veterans who died without receiving the benefits they should have received.
What Changed with the Blue Water Navy Vietnam Veterans Act and Nehmer Consent Decree?
The turning point came through two parallel legal and legislative processes. First, in 1986, Vietnam veterans filed a class-action lawsuit called *Nehmer v. U.S. Department of Veterans Affairs*, challenging the VA’s restrictive regulations that limited compensation for Agent Orange-related conditions. The case succeeded: in 1989, a federal court invalidated the VA’s overly narrow regulation, and in 1991, the Nehmer Consent Decree formalized the outcome, requiring the VA to recognize diseases associated with Agent Orange as service-connected and to review previously denied claims. However, even after Nehmer, the VA still maintained that offshore service didn’t qualify for presumed herbicide exposure.
This meant that while a soldier on land in Vietnam automatically received compensation for certain diseases, a Navy sailor in the same area but on a ship remained ineligible. This inconsistency persisted until 2019, when Congress passed Public Law 116-23, the Blue Water Navy Vietnam Veterans Act. The law took effect on January 1, 2020, extending the presumption of Agent Orange exposure to all veterans who served in offshore waters of the Republic of Vietnam between January 9, 1962, and May 7, 1975. A critical caveat applies here: the Blue Water Navy Act solved the offshore problem but initially only covered exposure in the Republic of Vietnam’s offshore waters. It did not immediately address herbicide exposure at other locations where U.S. forces operated, such as bases in Thailand, Japan, or Korean DMZ areas. The VA has since begun updating its regulations to close this remaining gap, with proposed amendments in February 2024 and finalized regulations in October 2024 that extend presumptions to additional locations where herbicides were used, tested, or stored outside Vietnam.
The Readjudication Program and Nehmer Eligibility
Beginning in April 2021, the VA launched its formal readjudication program, systematically reviewing claims from approximately 70,000 veterans and survivors identified as potentially eligible under the new offshore exposure rules. The program didn’t wait for veterans to reapply—the VA proactively identified eligible claimants from its records and began the review process. If your name was in the VA database with a prior denial for an Agent Orange condition, and you served offshore during the eligible timeframe, you likely received correspondence about the readjudication. For a veteran to qualify, three elements must align: you must have served during the eligible timeframe (January 9, 1962 to May 7, 1975), in the offshore waters of the Republic of Vietnam (generally defined as waters within the coastline), and you must have developed or been diagnosed with a condition on the VA’s list of Agent Orange-presumed diseases. The VA’s presumed conditions list includes various cancers, diabetes, heart disease, Parkinson’s disease, and several others.
You don’t have to prove exposure directly—if you meet the service criteria, the VA presumes you were exposed. The financial results have been substantial. Between 2021 and early 2023, the VA distributed approximately $201 million in back pay to nearly 7,000 “blue water” Navy Vietnam War veterans and their survivors. This back pay covers the period from the date the VA should have approved the claim under current law back to the original application date or date of discharge, whichever is later. For some veterans, this has meant six-figure payments covering decades of unpaid benefits.
Understanding Back Pay and Compensation Amounts
Back pay calculations in the readjudication program are based on the disability rating assigned—not all approvals result in the same payment. The VA rates disabilities from 0% to 100% in 10% increments, with each rating corresponding to a monthly benefit amount. A veteran approved with a 50% disability rating receives more monthly compensation than one approved at 30%, and the back pay is calculated by multiplying the monthly rate by the number of months between when the claim should have been approved and the current payment date. Consider a concrete example: a Navy veteran with a prior-denied claim for Agent Orange-related cancer files under the readjudication program in 2022. The VA approves him with a 70% disability rating, retroactive to the date of his 2010 denial (12 years earlier). If the monthly benefit for a 70% rating is $1,800, the veteran would receive approximately $259,200 in back pay (12 years × 12 months × $1,800).
Additionally, he would receive the current monthly rate going forward. Some veterans have received significantly larger lump sums when claims covered longer denial periods. However, there’s a limitation: back pay is not infinite. The VA cannot award back pay beyond the date you applied for benefits or your separation from service, even if the VA should have approved the claim decades earlier. Additionally, if you’ve already received some form of VA compensation or other federal benefits, those may offset the back pay amount. It’s crucial to understand your specific financial situation, which is why many veterans work with accredited representatives or veterans’ organizations to calculate anticipated payments before claims are finalized.
What About Veterans Who Already Died Without Receiving Benefits?
One of the most painful aspects of the offshore exposure denial policy is that many Vietnam War veterans died before the Blue Water Navy Act was passed, never knowing their claims would eventually be approved. However, the readjudication program extends to survivors of deceased veterans, meaning spouses, children, and dependent parents can inherit approved claims and receive Dependency and Indemnity Compensation (DIC) benefits. The process for survivors is more complex than for living veterans, but the principle is the same: if the deceased veteran would have qualified for compensation under the new rules, the survivor can receive benefits retroactive to when the original claim was filed.
A widow whose husband died in 2015 from a cancer linked to Agent Orange might discover, through the readjudication program, that his claim qualifies for approval. She could then receive years of accumulated DIC payments, though typically starting from the date of the VA’s formal approval rather than from the date of his death. There is an important deadline consideration: survivor benefits are time-sensitive, and there are limits on how far back DIC can be paid. If you believe you might be a survivor eligible for benefits, it’s important to contact the VA or a veterans’ service organization quickly to understand your specific eligibility and avoid missing any filing windows.
Recent Regulatory Expansions and Additional Locations
The readjudication program has continued to expand in scope. In February 2024, the VA proposed amendments to its adjudication regulations specifically to extend the presumed area of exposure for herbicide agents and to codify presumptions for locations where herbicides were used, tested, or stored outside Vietnam. These proposed amendments, finalized in October 2024, represent the next wave of eligibility expansion.
This regulatory update is significant because it addresses a remaining gap: veterans who served in Thailand at air bases where Agent Orange was stored, Korea at bases near the DMZ, or other locations where the U.S. military used or stored herbicides. A veteran who served at a maintenance facility in Thailand where Agent Orange-contaminated equipment was being repaired, or in South Korea during the War’s later years, may now qualify for presumed exposure under these expanded regulations. The VA is still processing how these new presumptions will be applied, so if you have service in locations beyond offshore Vietnam waters, contact the VA to learn whether your service qualifies under the updated rules.
The Broader Legacy and Future of VA Herbicide Exposure Claims
The offshore exposure denial and its eventual correction represent one of the largest-scale injustices in VA benefits administration—affecting hundreds of thousands of veterans over four decades. The cost to correct it has already exceeded $201 million, and the full scope of additional eligible veterans under the expanded regulations is still being determined. Some advocates believe the VA’s estimates of 70,000 eligible veterans may undercount the actual population, as the agency continues to identify veterans who qualify under the new and updated rules.
Looking forward, the expansion of herbicide exposure presumptions to additional locations and circumstances reflects a broader shift in how the VA approaches toxic exposure claims. Recent legislative efforts, including the Preventing All Cigarette Trafficking (PACT) Act and expanded burn pit exposure recognition, indicate that Congress and the VA are increasingly willing to recognize claims without requiring ironclad proof of individual exposure. This trend suggests that veterans from other eras and theaters of operation may eventually see similar expansions and readjudication programs, correcting decades of prior denials.